If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marcello Deraco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Drug Therapy Medicine & Life Sciences
Pseudomyxoma Peritonei Medicine & Life Sciences
Mesothelioma Medicine & Life Sciences
Perfusion Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

Papillary Carcinoma
Drug Therapy
Disease-Free Survival

Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: A retrospective study

Güadagni, S., Fiorentini, G., Palumbo, P., Masedu, F., Ricevuto, E., Brüera, G., Deraco, M., Küsamüra, S., Sarti, D., Fiorentini, C., Gailhofer, S. & Clementi, M., Jan 1 2019, In : Minerva Chirurgica. 74, 4, p. 304-312 9 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Palliative Care
Retrospective Studies

Isolated thoracic perfusion in lung metastases from breast cancer: a retrospective observational study

Guadagni, S., Aigner, K., Zoras, O., Masedu, F., Fiorentini, G., Ricevuto, E., Deraco, M. & Clementi, M., Mar 1 2019, In : Updates in Surgery. 71, 1, p. 165-177 13 p.

Research output: Contribution to journalArticle

Observational Studies
Retrospective Studies
Breast Neoplasms

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience

On behalf of the Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups, Mar 1 2019, In : Journal of Surgical Oncology. 119, 3, p. 336-346 11 p.

Research output: Contribution to journalArticle

Neoplasm Metastasis
Drug Therapy

Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei

Raimondi, A., Corallo, S., Niger, M., Antista, M., Randon, G., Morano, F., Milione, M., Kusamura, S., Baratti, D., Guaglio, M., Cremolini, C., Marmorino, F., Di Bartolomeo, M., Deraco, M., De Braud, F. & Pietrantonio, F., Jun 2019, In : Clinical Colorectal Cancer. 18, 2, p. e179-e190

Research output: Contribution to journalArticle

Pseudomyxoma Peritonei
Disease-Free Survival